Clinical definition of hereditary non-polyposis colorectal cancer: A search for the impossible?

被引:6
作者
Berends, MJW
Wu, Y
Sijmons, RH
Hofstra, RMW
van der Zee, AGJ
Buys, CHCM
Kleibeuker, JH
机构
[1] Univ Groningen Hosp, Dept Gastroenterol, NL-9700 RB Groningen, Netherlands
[2] Univ Groningen Hosp, Dept Med Genet, NL-9700 RB Groningen, Netherlands
[3] Univ Groningen Hosp, Dept Gynaecol, NL-9700 RB Groningen, Netherlands
关键词
diagnostic criteria; hereditary non-polyposis colorectal cancer; microsatellite instability; MSH6;
D O I
10.1080/003655201753265127
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Hereditary non-polyposis colorectal cancer is an autosomal dominant inherited disorder that predisposes its carriers to an almost 100% lifetime risk of cancer, in particular colorectal and endometrial cancer. Germline mutations, resulting in a deficient DNA mismatch repair system. are responsible for the disease. Because of the lack of specific phenotypical features, clinical diagnosis in an individual patient is impossible and relies heavily on family history. Genetic diagnosis by mismatch detection is now possible in a substantial proportion of families. Thus there is a great need for reliable but simple criteria that will help clinicians to recognize patients and families who can be referred for genetic diagnostics. In this article the different criteria that have been formulated and published in recent years are reviewed and the results, in terms of the proportions of subjects satisfying the criteria who were found to have a germline mutation, are discussed. In most studies the criteria were evaluated in only a small number of subjects. A population-based study is currently being carried out in the north of The Netherlands that aims to include 400 patients fulfilling one of a few simple criteria. Mutation analysis will be performed in all patients, The results of this study will help in the formulation of accurate and simple criteria for use in clinical practice.
引用
收藏
页码:61 / 67
页数:7
相关论文
共 65 条
[1]
Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease [J].
Aaltonen, LA ;
Salovaara, R ;
Kristo, P ;
Canzian, F ;
Hemminki, A ;
Peltomäki, P ;
Chadwick, RB ;
Kääriäinen, H ;
Eskelinen, M ;
Järvinen, H ;
Mecklin, JP ;
de la Chapelle, A ;
Percesepe, A ;
Ahtola, H ;
Härkönen, N ;
Julkunen, R ;
Kangas, E ;
Ojala, S ;
Tulikoura, J ;
ValKamo, E .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (21) :1481-1487
[2]
Aarnio M, 1999, INT J CANCER, V81, P214, DOI 10.1002/(SICI)1097-0215(19990412)81:2<214::AID-IJC8>3.3.CO
[3]
2-C
[4]
Akiyama Y, 1997, CANCER RES, V57, P3920
[5]
Bai YQ, 1999, INT J CANCER, V82, P512, DOI 10.1002/(SICI)1097-0215(19990812)82:4<512::AID-IJC7>3.0.CO
[6]
2-8
[7]
Family history characteristics, tumor microsatellite instability and germline MSH2 and MLH1 mutations in hereditary colorectal cancer [J].
Bapat, BV ;
Madlensky, L ;
Temple, LKF ;
Hiruki, T ;
Redston, M ;
Baron, DL ;
Xia, L ;
Marcus, VA ;
Soravia, C ;
Mitri, A ;
Shen, W ;
Gryfe, R ;
Berk, T ;
Chodirker, BN ;
Cohen, Z ;
Gallinger, S .
HUMAN GENETICS, 1999, 104 (02) :167-176
[8]
Berends MJW, 1999, AM J HUM GENET, V65, pA39
[9]
MUTATION IN THE DNA MISMATCH REPAIR GENE HOMOLOG HMLH1 IS ASSOCIATED WITH HEREDITARY NONPOLYPOSIS COLON-CANCER [J].
BRONNER, CE ;
BAKER, SM ;
MORRISON, PT ;
WARREN, G ;
SMITH, LG ;
LESCOE, MK ;
KANE, M ;
EARABINO, C ;
LIPFORD, J ;
LINDBLOM, A ;
TANNERGARD, P ;
BOLLAG, RJ ;
GODWIN, AR ;
WARD, DC ;
NORDENSKJOLD, M ;
FISHEL, R ;
KOLODNER, R ;
LISKAY, RM .
NATURE, 1994, 368 (6468) :258-261
[10]
Cravo ML, 1999, CANCER, V85, P779, DOI 10.1002/(SICI)1097-0142(19990215)85:4<779::AID-CNCR4>3.0.CO